Skip to main content
Top
Published in: European Journal of Nutrition 4/2016

01-06-2016 | Original Contribution

Bee’s honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein–NLRP3 inflammasome pathway

Authors: Jia Xiao, Yingxia Liu, Feiyue Xing, Tung Ming Leung, Emily C. Liong, George L. Tipoe

Published in: European Journal of Nutrition | Issue 4/2016

Login to get access

Abstract

Purpose

We aim to examine whether honey ameliorates hepatic injury in non-alcoholic steatohepatitis (NASH) animal and cell line steatosis models.

Methods

NASH was induced in female Sprague–Dawley rat by 8-week feeding with a high-fat diet. During the experiment, 5 g/kg honey was intragastrically fed daily. Rat normal hepatocyte BRL-3A cell was treated with sodium palmitate (SP) to induce steatosis in the absence or presence of honey pre-treatment or specific siRNA/overexpress plasmid of thioredoxin-interacting protein (TXNIP) or antagonist/agonist of Nod-like receptor protein 3 (NLRP3).

Results

Honey significantly improved the high-fat-diet-induced hepatic injury, steatosis, fibrosis, oxidative stress, and inflammation in rats. Honey also inhibited the overexpression of TXNIP and the activation of NLRP3 inflammasome. These effects were replicated in BRL-3A cell line which showed that the down-regulation of TXNIP or inhibition of NLRP3 contributed to the suppression of NLRP3 inflammasome activation, inflammation, and re-balanced lipid metabolism. In contrast, overexpression of TXNIP or agonism of NLRP3 exacerbated the cellular damage induced by SP.

Conclusion

Suppression of the TXNIP–NLRP3 inflammasome pathway may partly contribute to the amelioration of hepatic injury during the progression of NASH by honey. Targeting hepatic TXNIP–NLRP3 inflammasome pathway is a potential therapeutic way for the prevention and treatment of NASH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343:d6891CrossRef Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, Clark JM (2011) Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 343:d6891CrossRef
2.
go back to reference Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836–1846CrossRef Tilg H, Moschen AR (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52:1836–1846CrossRef
3.
go back to reference Xiao J, Guo R, Fung ML, Liong EC, Tipoe GL (2013) Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat Dis Int 12:125–135CrossRef Xiao J, Guo R, Fung ML, Liong EC, Tipoe GL (2013) Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. Hepatobiliary Pancreat Dis Int 12:125–135CrossRef
4.
go back to reference Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179–185 Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179–185
5.
go back to reference Benetti E, Chiazza F, Patel NS, Collino M (2013) The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm 2013:678627 Benetti E, Chiazza F, Patel NS, Collino M (2013) The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm 2013:678627
6.
go back to reference Xiao J, Ching YP, Liong EC, Nanji AA, Fung ML, Tipoe GL (2013) Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Euro J Nutr 52:179–191CrossRef Xiao J, Ching YP, Liong EC, Nanji AA, Fung ML, Tipoe GL (2013) Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Euro J Nutr 52:179–191CrossRef
7.
go back to reference Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, Xu AM, So KF, Tipoe GL (2013) Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury. Nutr Diabetes 3:e81CrossRef Xiao J, Liong EC, Ching YP, Chang RC, Fung ML, Xu AM, So KF, Tipoe GL (2013) Lycium barbarum polysaccharides protect rat liver from non-alcoholic steatohepatitis-induced injury. Nutr Diabetes 3:e81CrossRef
8.
go back to reference Li L, Hai J, Li Z, Zhang Y, Peng H, Li K, Weng X (2014) Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem Toxicol 63:166–173CrossRef Li L, Hai J, Li Z, Zhang Y, Peng H, Li K, Weng X (2014) Resveratrol modulates autophagy and NF-kappaB activity in a murine model for treating non-alcoholic fatty liver disease. Food Chem Toxicol 63:166–173CrossRef
9.
go back to reference Zhang Y, Hai J, Cao M, Zhang Y, Pei S, Wang J, Zhang Q (2013) Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. Int Immunopharmacol 17:714–720CrossRef Zhang Y, Hai J, Cao M, Zhang Y, Pei S, Wang J, Zhang Q (2013) Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway. Int Immunopharmacol 17:714–720CrossRef
10.
go back to reference Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA (2012) Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55:429–436CrossRef Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA (2012) Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55:429–436CrossRef
11.
go back to reference Muhammad A, Odunola OA, Gbadegesin MA, Adegoke AM, Olugbami JO, Uche NS (2015) Modulatory role of Acacia honey from north-west Nigeria on sodium arsenite-induced clastogenicity and oxidative stress in male Wistar rats. Nat Prod Res 29:321–326CrossRef Muhammad A, Odunola OA, Gbadegesin MA, Adegoke AM, Olugbami JO, Uche NS (2015) Modulatory role of Acacia honey from north-west Nigeria on sodium arsenite-induced clastogenicity and oxidative stress in male Wistar rats. Nat Prod Res 29:321–326CrossRef
12.
go back to reference Al-Malki AL, Sayed AA (2013) Bees’ honey attenuation of metanil-yellow-induced hepatotoxicity in rats. Evid Based Complement Alternat Med 2013:614580 Al-Malki AL, Sayed AA (2013) Bees’ honey attenuation of metanil-yellow-induced hepatotoxicity in rats. Evid Based Complement Alternat Med 2013:614580
13.
go back to reference Al-Yahya M, Mothana R, Al-Said M, Al-Dosari M, Al-Musayeib N, Al-Sohaibani M, Parvez MK, Rafatullah S (2013) Attenuation of CCl4-induced oxidative stress and hepatonephrotoxicity by Saudi Sidr Honey in rats. Evid Based Complement Alternat Med 2013:569037CrossRef Al-Yahya M, Mothana R, Al-Said M, Al-Dosari M, Al-Musayeib N, Al-Sohaibani M, Parvez MK, Rafatullah S (2013) Attenuation of CCl4-induced oxidative stress and hepatonephrotoxicity by Saudi Sidr Honey in rats. Evid Based Complement Alternat Med 2013:569037CrossRef
14.
go back to reference Jubri Z, Rahim NB, Aan GJ (2013) Manuka honey protects middle-aged rats from oxidative damage. Clinics 68:1446–1454CrossRef Jubri Z, Rahim NB, Aan GJ (2013) Manuka honey protects middle-aged rats from oxidative damage. Clinics 68:1446–1454CrossRef
15.
go back to reference Abdel Aziz A, Rady H, Amer M, Kiwan H (2009) Effect of some honey bee extracts on the proliferation, proteolytic and gelatinolytic activities of the hepatocellular carcinoma Hepg2 cell line. Austr J Basic Appl Sci 3:2754–2769 Abdel Aziz A, Rady H, Amer M, Kiwan H (2009) Effect of some honey bee extracts on the proliferation, proteolytic and gelatinolytic activities of the hepatocellular carcinoma Hepg2 cell line. Austr J Basic Appl Sci 3:2754–2769
16.
go back to reference El-kott AF, Kandeel AA, El-Aziz SFA, Ribea HM (2012) Anti-tumor effects of bee honey on PCNA and P53 expression in the rat hepatocarcinogenesis. Int J Cancer Res 8:130–139CrossRef El-kott AF, Kandeel AA, El-Aziz SFA, Ribea HM (2012) Anti-tumor effects of bee honey on PCNA and P53 expression in the rat hepatocarcinogenesis. Int J Cancer Res 8:130–139CrossRef
17.
go back to reference Erejuwa OO, Gurtu S, Sulaiman SA, Ab Wahab MS, Sirajudeen KN, Salleh MS (2010) Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitamin Nutrit Res. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 80:74–82 Erejuwa OO, Gurtu S, Sulaiman SA, Ab Wahab MS, Sirajudeen KN, Salleh MS (2010) Hypoglycemic and antioxidant effects of honey supplementation in streptozotocin-induced diabetic rats. Int J Vitamin Nutrit Res. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 80:74–82
18.
go back to reference Fasanmade AA, Alabi OT (2008) Differential effect of honey on selected variables in alloxan-induced and fructose-induced diabetic rats. Afr J BiomedRes 11:191–196 Fasanmade AA, Alabi OT (2008) Differential effect of honey on selected variables in alloxan-induced and fructose-induced diabetic rats. Afr J BiomedRes 11:191–196
19.
go back to reference Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA (2009) Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol Histopathol 24:1161–1169 Tipoe GL, Ho CT, Liong EC, Leung TM, Lau TY, Fung ML, Nanji AA (2009) Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD). Histol Histopathol 24:1161–1169
20.
go back to reference Xiao J, Guo R, Fung ML, Liong EC, Chang RC, Ching YP, Tipoe GL (2013) Garlic-derived S-Allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy. Evid Based Complement Alternat Med 2013:642920 Xiao J, Guo R, Fung ML, Liong EC, Chang RC, Ching YP, Tipoe GL (2013) Garlic-derived S-Allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy. Evid Based Complement Alternat Med 2013:642920
21.
go back to reference Medhi B, Prakash A, Avti PK, Saikia UN, Pandhi P, Khanduja KL (2008) Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J Exp Biol 46:583–590 Medhi B, Prakash A, Avti PK, Saikia UN, Pandhi P, Khanduja KL (2008) Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats. Indian J Exp Biol 46:583–590
22.
go back to reference Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321CrossRef
23.
go back to reference Wang W, Wang C, Ding XQ, Pan Y, Gu TT, Wang MX, Liu YL, Wang FM, Wang SJ, Kong LD (2013) Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. Br J Pharmacol 169:1352–1371CrossRef Wang W, Wang C, Ding XQ, Pan Y, Gu TT, Wang MX, Liu YL, Wang FM, Wang SJ, Kong LD (2013) Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. Br J Pharmacol 169:1352–1371CrossRef
24.
go back to reference Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622CrossRef Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622CrossRef
25.
go back to reference Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A (2006) Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 40:930–935CrossRef Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A (2006) Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol 40:930–935CrossRef
26.
go back to reference Muoio DM (2007) TXNIP links redox circuitry to glucose control. Cell Metab 5:412–414CrossRef Muoio DM (2007) TXNIP links redox circuitry to glucose control. Cell Metab 5:412–414CrossRef
27.
go back to reference Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210–215CrossRef Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210–215CrossRef
28.
go back to reference Jubri Z, Narayanan N, Karim N, Ngah W (2012) Antiproliferative activity and apoptosis induction by Gelam Honey on liver cancer cell line. Int J Appl Sci Technol 2:7 Jubri Z, Narayanan N, Karim N, Ngah W (2012) Antiproliferative activity and apoptosis induction by Gelam Honey on liver cancer cell line. Int J Appl Sci Technol 2:7
29.
go back to reference Bogdanov S, Jurendic T, Sieber R, Gallmann P (2008) Honey for nutrition and health: a review. J Am Coll Nutr 27:677–689CrossRef Bogdanov S, Jurendic T, Sieber R, Gallmann P (2008) Honey for nutrition and health: a review. J Am Coll Nutr 27:677–689CrossRef
30.
go back to reference Gheldof N, Wang XH, Engeseth NJ (2002) Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem 50:5870–5877CrossRef Gheldof N, Wang XH, Engeseth NJ (2002) Identification and quantification of antioxidant components of honeys from various floral sources. J Agric Food Chem 50:5870–5877CrossRef
31.
go back to reference Beretta G, Gelmini F, Lodi V, Piazzalunga A, Maffei Facino R (2010) Profile of nitric oxide (NO) metabolites (nitrate, nitrite and N-nitroso groups) in honeys of different botanical origins: nitrate accumulation as index of origin, quality and of therapeutic opportunities. J Pharm Biomed Anal 53:343–349CrossRef Beretta G, Gelmini F, Lodi V, Piazzalunga A, Maffei Facino R (2010) Profile of nitric oxide (NO) metabolites (nitrate, nitrite and N-nitroso groups) in honeys of different botanical origins: nitrate accumulation as index of origin, quality and of therapeutic opportunities. J Pharm Biomed Anal 53:343–349CrossRef
32.
go back to reference Wang J, Li QX (2011) Chemical composition, characterization, and differentiation of honey botanical and geographical origins. Adv Food Nutr Res 62:89–137CrossRef Wang J, Li QX (2011) Chemical composition, characterization, and differentiation of honey botanical and geographical origins. Adv Food Nutr Res 62:89–137CrossRef
33.
go back to reference Van Schaftingen E, Davies DR (1991) Fructose administration stimulates glucose phosphorylation in the livers of anesthetized rats. FASEB J 5:326–330 Van Schaftingen E, Davies DR (1991) Fructose administration stimulates glucose phosphorylation in the livers of anesthetized rats. FASEB J 5:326–330
34.
go back to reference Memon MQ, Kumar A (2013) The fructose mystery: how bad or good is it? Pak J Pharm Sci 26:1241–1245 Memon MQ, Kumar A (2013) The fructose mystery: how bad or good is it? Pak J Pharm Sci 26:1241–1245
35.
go back to reference Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr 4:109–116 Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nutr 4:109–116
36.
go back to reference Nemoseck TM, Carmody EG, Furchner-Evanson A, Gleason M, Li A, Potter H, Rezende LM, Lane KJ, Kern M (2011) Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res 31:55–60CrossRef Nemoseck TM, Carmody EG, Furchner-Evanson A, Gleason M, Li A, Potter H, Rezende LM, Lane KJ, Kern M (2011) Honey promotes lower weight gain, adiposity, and triglycerides than sucrose in rats. Nutr Res 31:55–60CrossRef
37.
go back to reference Bahrami M, Ataie-Jafari A, Hosseini S, Foruzanfar MH, Rahmani M, Pajouhi M (2009) Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr 60:618–626CrossRef Bahrami M, Ataie-Jafari A, Hosseini S, Foruzanfar MH, Rahmani M, Pajouhi M (2009) Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr 60:618–626CrossRef
38.
go back to reference Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y (2002) Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 132:3379–3382 Busserolles J, Gueux E, Rock E, Mazur A, Rayssiguier Y (2002) Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 132:3379–3382
39.
go back to reference Chepulis L, Starkey N (2008) The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. J Food Sci 73:H1–H7CrossRef Chepulis L, Starkey N (2008) The long-term effects of feeding honey compared with sucrose and a sugar-free diet on weight gain, lipid profiles, and DEXA measurements in rats. J Food Sci 73:H1–H7CrossRef
40.
go back to reference Zhou J, Chng WJ (2013) Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion 13:163–169CrossRef Zhou J, Chng WJ (2013) Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion 13:163–169CrossRef
41.
go back to reference Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140CrossRef Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136–140CrossRef
Metadata
Title
Bee’s honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein–NLRP3 inflammasome pathway
Authors
Jia Xiao
Yingxia Liu
Feiyue Xing
Tung Ming Leung
Emily C. Liong
George L. Tipoe
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 4/2016
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-015-0964-4

Other articles of this Issue 4/2016

European Journal of Nutrition 4/2016 Go to the issue